BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34616846)

  • 21. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
    Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
    Front Genet; 2023; 14():1109991. PubMed ID: 36992705
    [No Abstract]   [Full Text] [Related]  

  • 22. Potential Diagnostic and Prognostic Values of CBX8 Expression in Liver Hepatocellular Carcinoma, Kidney Renal Clear Cell Carcinoma, and Ovarian Cancer: A Study Based on TCGA Data Mining.
    Lin J; Chen L; Wu D; Lin J; Liu B; Guo C
    Comput Math Methods Med; 2022; 2022():1372879. PubMed ID: 35813444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
    Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
    Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
    Kayama K; Watanabe S; Takafuji T; Tsuji T; Hironaka K; Matsumoto M; Nakayama KI; Enari M; Kohno T; Shiraishi K; Kiyono T; Yoshida K; Sugimoto N; Fujita M
    EMBO Rep; 2017 Jan; 18(1):123-137. PubMed ID: 27856536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors.
    Mao W; Zhou J; Hu J; Zhao K; Fu Z; Wang J; Mao K
    Front Public Health; 2022; 10():969070. PubMed ID: 36051999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment.
    Wen J; Mao X; Cheng Q; Liu Z; Liu F
    Sci Rep; 2021 Nov; 11(1):22502. PubMed ID: 34795387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
    Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
    Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
    [No Abstract]   [Full Text] [Related]  

  • 29. The Role of NCS1 in Immunotherapy and Prognosis of Human Cancer.
    Wang GC; Gan X; Zeng YQ; Chen X; Kang H; Huang SW; Hu WH
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression profile and prognostic values of GATA family members in kidney renal clear cell carcinoma.
    Yang X; Mei C; Nie H; Zhou J; Ou C; He X
    Aging (Albany NY); 2023 Mar; 15(6):2170-2188. PubMed ID: 36961416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors.
    Zhang D; Wang T; Zhou Y; Zhang X
    Medicine (Baltimore); 2023 Apr; 102(14):e33468. PubMed ID: 37026918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
    Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic Analysis of the Oncogenic Role of WDR62 in Human Tumors.
    Bu Y; Zhang L; Ma X; Wang R; Zhang X; Li J
    Dis Markers; 2021; 2021():9940274. PubMed ID: 34306258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and immunological role of FDX1 in pan-cancer: an in-silico analysis.
    Liu Z; Miao J
    Sci Rep; 2023 May; 13(1):7926. PubMed ID: 37193786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GRWD1 promotes cell proliferation and migration in non-small cell lung cancer by activating the Notch pathway.
    Wang Q; Ren H; Xu Y; Jiang J; Wudu M; Liu Z; Su H; Jiang X; Zhang Y; Zhang B; Qiu X
    Exp Cell Res; 2020 Feb; 387(2):111806. PubMed ID: 31891681
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Klümper N; Ralser DJ; Bawden EG; Landsberg J; Zarbl R; Kristiansen G; Toma M; Ritter M; Hölzel M; Ellinger J; Dietrich D
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32234847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and Diagnostic Values of Semaphorin 5B and Its Correlation With Tumor-Infiltrating Immune Cells in Kidney Renal Clear-Cell Carcinoma.
    Ding J; Zhao S; Chen X; Luo C; Peng J; Zhu J; Shen Y; Luo Z; Chen J
    Front Genet; 2022; 13():835355. PubMed ID: 35480320
    [No Abstract]   [Full Text] [Related]  

  • 38. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
    Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
    Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatic analyses reveal the prognostic significance and potential role of ankyrin 3 (ANK3) in kidney renal clear cell carcinoma.
    Somsuan K; Aluksanasuwan S
    Genomics Inform; 2023 Jun; 21(2):e22. PubMed ID: 37423640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comprehensive Analysis of the Glutathione Peroxidase 8 (GPX8) in Human Cancer.
    Ren Z; He Y; Yang Q; Guo J; Huang H; Li B; Wang D; Yang Z; Tian X
    Front Oncol; 2022; 12():812811. PubMed ID: 35402257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.